Plenary Keynotes:
- - Jeffrey C. Baker, Ph.D., Deputy Director, Office of Biotechnology Products, CDER, U.S. FDA
- - Jonathan Coffman, Ph.D., Associate Research Fellow, Pfizer, Inc. Duncan Low, Ph.D., Scientific Executive Director, Process and Product Engineering, Amgen
- - Yongjick Kim, Ph.D., President, Manufacturing and Technical Operations, Celltrion, Korea
- - Drew Kelner, Ph.D., Executive Director, Global Analytical Sciences, Amgen
Session Keynotes:
- - DC Characterization from Fred Jacobson, Ph.D., Principal Scientist, Genentech Inc., a member of the Roche Group Thomas
- - Promise of Biosimilars from Vanden Boom, Ph.D., Vice President, Global Biologics Research, Development and Manufacturing Operations, Hospira Inc..
- - Controlling Raw Materials form Rob Gronke, Ph.D, Senior Principal Scientiest, Biogen Idec
- - Integrating Analytics from Mary E.M. Cromwell, Ph.D., Director, Late Stage Pharmaceutical Development, Genentech, a member of the Roche Group
- - Bioproduction Innovation from Abhinav Shukla, Ph.D., Vice President, Process Development and Manufacturing, KBI Biopharma
- - Disruptive Purification Methods from Pete Gagnon, Senior Research Technology Specialist, Bioprocessing Technology Institute, Singapore
- - Drug Substance Fragmentation from E. Morrey Atkinson, Ph.D., Vice President, Process Sciences, Bristol-Myers Squibb
To find out more about these sessions and the rest of the agenda, download the brochure.
Biopharmaceutical Development and Production Week will take place February 25-April 1, 2013 in Huntington Beach, California. As a reader of this blog, when you register to join us and mention code BDP13JP, you’ll save 20% off the standard rate!* If you have any questions about the event, feel free to reach out to Jennifer Pereira.
*This does not apply if you've already registered to join us at BDP Week 2013
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment